Trial Profile

A Double-Blind Sequential Parallel Study of Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

Status: Not yet recruiting

Phase of Trial: Phase IV

Latest Information Update: 23 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Suvorexant (Primary)
Indications Bipolar depression; Bipolar I disorders; Bipolar II disorders
Focus Therapeutic Use

Most Recent Events

18 Feb 2021 Status changed from withdrawn prior to enrolment to not yet recruiting.
18 Feb 2021 Status changed from not yet recruiting to withdrawn prior to enrolment. (Study was terminated due to COVID-19).
12 Aug 2019 Planned initiation date changed from 1 Jan 2019 to 1 Sep 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com